Cannabis stocks news - daily news on stocks on CSE, TSX, TSXV, OTC, NASDAQ and NYSE from InvestorIdeas.com
Monday, 31 July 2023
Psilocybin Stock News: Red Light Holland (CSE: TRIP) (OTCQB: TRUFF) Reports 2023 Audited Year End Results
Wednesday, 26 July 2023
Hemp Stock News: Hempacco (NASDAQ: HPCO) Signs New Master Distributor in New York
Monday, 24 July 2023
Cannabis Stock News: Body and Mind (CSE: BAMM) Announces Agreement to Divest Ohio Dispensary
Thursday, 20 July 2023
Cannabis Stock News: InMed (NASDAQ: INM) Provides Update on BayMedica Rare Cannabinoid Business
Tuesday, 18 July 2023
Hemp Stock News: Hempacco (NASDAQ: HPCO) to Launch Snoop Dogg's "Dogg lbs" Gummies at the Champs Show in Las Vegas
Thursday, 6 July 2023
Growpacker Cannabis Workers Join Teamsters Local 1932
Friday, 16 June 2023
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (NASDAQ: $ACB) (TSX: $ACB.TO) (NASDAQ: $HEXO) (TSX: $HEXO.TO)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (NASDAQ: $ACB) (TSX: $ACB.TO)
(NASDAQ: $HEXO) (TSX: $HEXO.TO)
Delta, Kelowna, BC, June 16, 2023
(Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/061623-Cannabis.mp3
Read
this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/06161ACB-HEXO.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we go over a few
public company announcements, Canadian cannabis and indigenous communities as
well as a new potential source for CBD.
In recent news, Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), like many Canadian LP's, has been
looking to increase savings after wrapping a transformation plan that delivered
at least $400 million in savings over the last three years.
The company announced on Wednesday with its financial
reports, that it wants to uncover another $40 million in savings by the end of
next March, which marks the end of the company’s fiscal year.
“This incremental reduction puts us
squarely on the path to reach our next financial milestone, which is positive
free cash flow,” Miguel Martin announced on a call with analysts.
Free cash flow is an indicator of a
company’s financial performance because it encapsulates money a company makes
after accounting for expenses that support operations.
Profitability has been difficult across
Canada’s cannabis industry, where a lack of demand, strict regulations and the
strength of the illicit market have hampered the financial performance of most
businesses. Many, including Aurora and its rivals, have resorted to layoffs,
facility closures and intense evaluations of their product mix to weather such
conditions.
Aurora, which has been pursuing sales in
several European markets, recently decided to close its Nordic production
facility in Denmark and rely on its Canadian facilities to supply the market.
The Canadian facilities have lower per unit
costs, higher quality and a much more reliable supply, chief financial officer
Glen Ibbott said on the same call as Martin.
“We believe this change, in addition to
reduced costs, will allow us to compete even more effectively in the growing
European market, where we already have a substantial leadership position,” he
said.
Across the entire business this fiscal
year, he said Aurora was aiming to take away at least $5 million quarterly as
less efficient operations are eliminated and at least another $5 million from
cost reduction initiatives.
He also expects the company to save about
$2 million per quarter in interest as it pays off the remainder of its
convertible debt, which stands at about $80 million. Ibbot said Aurora intends
to pay the debt off at the end of this fiscal year.
In a recent article from MJBiz Daily, another
Canadian LP, Hexo Corp. (NASDAQ: HEXO) (TSX: HEXO) reported a total net loss before
tax of 129.7 million Canadian dollars ($98 million)
in the company’s third quarter, bringing accumulated losses since 2016 to more
than CA$2 billion. Hexo disclosed plunging revenue while reporting its fiscal
third quarter Thursday.
In the February-April period, Hexo’s net
sales were CA$21.6 million, down by approximately 50% compared to the same
period last year.
In that same quarter, recreational cannabis
sold at retail was CA$26.5 million, down 46% from last year., medical sales
were CA$647,000, down 28% from last year and International revenue fell 90%
compared to last year, to CA$649,000.
The only revenue stream that did not
experience a significant year-over-year decline was wholesale transactions.
Hexo’s wholesale sales increased 22% over last year’s quarter to CA$4 million.
In a conference call with an analyst, Hexo
CEO Charlie Bowman blamed:
●
Soft performance in key
markets, including Alberta, Ontario and Quebec.
●
Fierce competition within
the industry.
●
SKU rationalization in
which Hexo discontinues poorly performing product offerings.
Another reason was that its subsidiary,
Zenabis Global filed for bankruptcy protection and was
therefore deconsolidated from Hexo’s earnings.
Hexo has not generated positive cash flow
or earnings since 2016, the company also disclosed. Also in the third quarter,
Hexo said it entered into a definitive agreement for Tilray to acquire all of
Hexo’s outstanding shares.
Hexo said its shareholders approved Tilray’s acquisition of the issued
and outstanding common shares of the Quebec company.
The final arrangement between Hexo and
Tilray remains subject to court approval.
In other news from Canada, a Senate
committee recently commented on how the current cannabis
market and legislation has kept Indigenous Peoples from sharing in the economic
opportunities that the legalisation of recreational cannabis has created.
The standing Senate committee on Indigenous
Peoples said Thursday that it wants the country to shift its approach to
cannabis to help Indigenous communities and entrepreneurs better benefit from
the pot market.
A review the committee undertook left
members "severely disappointed but not surprised" to hear that
Indigenous Peoples found themselves often shut out of or facing additional
barriers in the cannabis market.
"Once again, Indigenous Peoples have
been excluded from participation in the economic prosperity of the
country," said Brian Francis, a P.E.I senator hailing from Lennox Island
First Nation, at a press conference in Ottawa.
"And once again, little regard has
been given to how our lives have been impacted."
The committee he sat on found the
Indigenous community's difficulties in fully taking advantage of cannabis
legalisation stem from legislation around the sale and distribution of
cannabis, licensing and even the regulation and policing of the substance.
Many problems the community faces were
identified before legalisation happened in October 2018 in consultations that
were "inadequate at best" and "could and should have been
addressed five years ago," Francis said.
"This oversight, to put it as
charitably as I can, cannot readily be corrected," he said.
"The cannabis market is now largely
saturated. First Nations entrepreneurs will have to work twice as hard to gain
a foothold in this market."
The committee found some First Nations are
completely blocked from participating in the cannabis market because the
federal government set the scope of the legal sale and distribution of pot, but
left regulation of legal activity to provinces and territories.
This meant some First Nations groups had to
enter into regulation and sale agreements with provinces and territories
While agreements have been reached in
British Columbia, Ontario and Saskatchewan, Indigenous communities told the
committee Quebec and the Northwest Territories have not made similar moves.
Thus, the committee would like the Minister
of Health to amend the Cannabis Act to permit First Nations to regulate the
possession, sale and distribution of cannabis on their lands. It is also
recommending a meeting be held with First Nations, federal, provincial and territorial
governments to solve jurisdictional challenges they face.
Legislation has also left few Indigenous
communities with the licences from Health Canada and the Canada Revenue Agency
(CRA) that are necessary to operate in the cannabis industry.
As of last September, the committee counted
55 Indigenous-affiliated applicants for commercial cannabis licences, with 12
of those located in First Nations communities. Some 47 Indigenous-owned or
affiliated businesses have received commercial licences, including six in First
Nations communities.
The committee feels this number is small
and indicates Indigenous cannabis entrepreneurs may face additional barriers in
the licensing process, so it would like the CRA to review the licensing
process.
The committee also turned its attention to
the excise tax, which is imposed on cannabis products when they're delivered to
buyers and shared between the federal, provincial and territorial governments.
For dried and fresh cannabis, plants and
seeds, the tax amounts to the higher of $1 per gram or a 10 per cent per gram
fee.
For edibles, extracts and topicals, it's a
flat rate based on the number of milligrams of total THC in the product. There
are additional duties in Alberta, Nunavut, Ontario and Saskatchewan.
First Nations communities do not receive a
portion of the tax, but the committee wants the government to look at how they
could share in the levy.
Rounding out the recommendations were
suggestions around the policing, research and medical insurance related to cannabis,
along with the committee urging the government to hear from the Inuit and Metis
communities, which it did not reach because of the COVID-19 pandemic.
"There's certainly some work that
still has to be done, but I would say this is a golden opportunity for the
government to act," said David Arnot, a Saskatchewan senator, at the same
conference as Francis.
"We've given them clear
recommendations and if they follow those recommendations, that will really set
the stage for a reconciliation, certainly, economic reconciliation."
In the world of CBD news, a recent news article says Scientists have
apparently discovered cannabidiol, also known as CBD, in a common Brazilian
plant, opening potential new avenues to produce the increasingly popular
substance, a lead researcher said Thursday.
The team found CBD in the fruits and
flowers of a plant known as Trema
micrantha blume, a shrub which grows across much of the South
American country and is often considered a weed, molecular biologist Rodrigo
Moura Neto of the Federal University of Rio de Janeiro told AFP.
CBD, increasingly used by some to treat
conditions including epilepsy, chronic pain and anxiety, is one of the main
active compounds in cannabis, along with tetrahydrocannabinol, or THC – the
substance that makes users feel high.
The compound's effectiveness as a medical
treatment is still under research.
Neto said chemical analysis had found
"Trema" contains CBD but not THC, raising the possibility of an
abundant new source of the former – one that would not face the legal and
regulatory hurdles of cannabis, which continues to be outlawed in many places,
including Brazil.
"It's a legal alternative to using
cannabis," he said.
"This is a plant that grows all over
Brazil. It would be a simpler and cheaper source of cannabidiol."
Scientists had previously found CBD in a
related plant in Thailand, he said.
Neto, who has not yet published his
results, said he now plans to scale up his study to identify the best methods
to extract CBD from "Trema" and analyse its effectiveness in patients
with conditions currently treated with medical cannabis.
His team recently won a 500,000-real
(US$104,000) grant from the Brazilian government to fund the research, which he
estimates will take at least five years to complete.
A study last year by market analysis firm
Vantage Market Research estimated the global market for CBD at nearly US$5
billion, and projected it would grow to more than US$47 billion by 2028, driven
mainly by health and wellness use.
Lastly, if you like myself and many others
are suffering from seasonal allergies or lung irritations from smoking, there’s
one local “weed” you may want to look into, mullein.
Verbascum thapsus, more commonly known as
mullein, is a member of the snapdragon family. It’s considered a
weed by some and a godsend by others.
The plant has been shown to aid in
loosening mucus, calming inflammation and fighting germs.
In health stores, you can find mullein
extracts, capsules, oils and teas. For respiratory issues, take mullein by
mouth. People often drink mullein tea — sipping a cup of tea of any kind is
soothing, and mullein may add health benefits. You can also take a mullein
capsule, extract or oil. Mullein benefits your respiratory tract — especially
when fighting illness.
You also go out and harvest some yourself
and it could become a great addition to any joint or bong bowl.
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and that
this podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking
stock news, third party stock research , guest posts and original articles and podcasts in leading stock
sectors. Learn about investing in stocks
and get investor ideas in cannabis,
crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and
more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner ,
Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change ,
Exploring Mining , Betting on Gaming Stocks Podcast and
the
AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except
where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections
Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections : Public Support for Legalization...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...
-
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T...
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...